Margaret R. Wallace

14.6k citations

157 papers · 9.0k indexed · 2 hit papers · h-index 44

Neurology top 0.2%
- Neurofibromatosis and Schwannoma Cases 73
- Neuroblastoma Research and Treatments 24
Cellular and Molecular Neuroscience top 1%
Rheumatology top 1%
- Soft tissue tumor case studies 20
Anesthesiology and Pain Medicine top 1%
Cell Biology top 1%
Pulmonary and Respiratory Medicine
- Sarcoma Diagnosis and Treatment 34
Pharmacology
- Musculoskeletal pain and rehabilitation 16
Epidemiology
- Meningioma and schwannoma management 13
Molecular Biology
- Amyloidosis: Diagnosis, Treatment, Outcomes 10
Surgery
- Shoulder Injury and Treatment 10

Co-authors: Francis S. Collins Lone B. Andersen Ann M. Saulino Douglas A. Marchuk James F. Gusella Roger B. Fillingim P. Michael Conneally Anna L. Mitchell
Cited by: Neurology Cellular and Molecular Neuroscience Rheumatology
Journals: Nature (2 papers)Science (3 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Margaret R. Wallace

153 papers receiving 8.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Margaret R. Wallace

Since Specialization

Citations

This map shows the geographic impact of Margaret R. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret R. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret R. Wallace more than expected).

Fields of papers citing papers by Margaret R. Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret R. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret R. Wallace. The network helps show where Margaret R. Wallace may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Margaret R. Wallace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Margaret R. Wallace Line = papers co-authored together Margaret R. Wallace links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Bevacizumab-Associated Enterocutaneous Fistula: A Case Report and Management Review Cureus ·Margaret R. Wallace,Linda Akbarshahi,M. Gene Bond,Tembele Yangandawele,Thomas R. Howdieshell	2025	0
2	Circulating Inflammatory Biomarkers Predict Pain Change Following Exercise-Induced Shoulder Injury: Findings From the Biopsychosocial Influence on Shoulder Pain Preclinical Trial Journal of Pain ·Corey B. Simon,Mark D. Bishop,Margaret R. Wallace,Roland Staud,Natalie DelRocco,Samuel S. Wu,Yunfeng Dai,Paul A. Borsa,Warren H. Greenfield,Roger B. Fillingim,Steven Z. George	2023	3
3	Analysis of AVPR1A, thermal and pressure pain thresholds, and stress in sickle cell disease SHILAP Revista de lepidopterología ·Keesha Powell-Roach,Yingwei Yao,Xueyuan Cao,Srikar Chamala,Margaret R. Wallace,Yenisel Cruz‐Almeida,Robert E. Molokie,Zaijie Jim Wang,Diana J. Wilkie	2023	2
4	A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors Molecular Cancer Therapeutics ·Juana Fernández‐Rodríguez,Edgar Creus‐Bachiller,Xiaohu Zhang,María Martínez‐Iniesta,Sara Ortega‐Bertran,Rajarshi Guha,Craig J. Thomas,Margaret R. Wallace,Cleofé Romagosa,Lourdes Salazar-Huayna,Karlyne M. Reilly,Jaishri O. Blakely,Jordi Serra-Musach,Miguel Ángel Pujana,Eduard Serra,Alberto Villanueva,Marc Ferrer,Conxi Lázaro	2022	7
5	Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1–associated atypical neurofibromas Neuro-Oncology ·Alexander Pemov,Nancy F. Hansen,Sivasish Sindiri,Rajesh Patidar,Christine S. Higham,Eva Dombi,Markku Miettinen,Patricia Fetsch,Hilde Brems,Settara C. Chandrasekharappa,Kristine Jones,Bin Zhu,Jun S. Wei,James C. Mullikin,Margaret R. Wallace,Javed Khan,Eric Legius,Brigitte C. Widemann,Douglas R. Stewart	2019	69
6	Immortalization of human normal and NF1 neurofibroma Schwann cells Laboratory Investigation ·Hua Li,Lung‐Ji Chang,Debbie Neubauer,David Muir,Margaret R. Wallace	2016	64
7	Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance Cancer Discovery ·Adrienne L. Watson,Eric P. Rahrmann,Branden S. Moriarity,Kwangmin Choi,Caitlin B. Conboy,Andrew D. Greeley,Amanda L. Halfond,Leah K. Anderson,Brian R. Wahl,Vincent W. Keng,Anthony E. Rizzardi,Colleen L. Forster,Margaret H. Collins,Aaron L. Sarver,Margaret R. Wallace,Stephen C. Schmechel,Nancy Ratner,David A. Largaespada	2013	76
8	Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2–Deficient Target Cell Types Molecular Cancer Research ·Marianne F. James,Elizabeth Stivison,Roberta L. Beauchamp,Sangyeul Han,Hua Li,Margaret R. Wallace,James F. Gusella,Anat Stemmer‐Rachamimov,Vijaya Ramesh	2012	81
9	Variation in the Gene TAS2R13 is Associated with Differences in Alcohol Consumption in Patients with Head and Neck Cancer Chemical Senses ·Cedrick D. Dotson,Margaret R. Wallace,Linda M. Bartoshuk,Henrietta L. Logan	2012	44
10	Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin Clinical Cancer Research ·Trent R. Hummel,Walter J. Jessen,Shyra J. Miller,Lan Kluwe,Victor F. Mautner,Margaret R. Wallace,Conxi Lázaro,Grier P. Page,Paul Worley,Bruce J. Aronow,Elizabeth K. Schorry,Nancy Ratner	2010	37
11	Evidence for a biopsychosocial influence on shoulder pain: Pain catastrophizing and catechol- O -methyltransferase (COMT) diplotype predict clinical pain ratings Pain ·Steven Z. George,Margaret R. Wallace,Thomas W. Wright,Michael W. Moser,Warren H. Greenfield,Brandon K. Sack,Deborah M. Herbstman,Roger B. Fillingim	2007	135
12	p53 regulates FAK expression in human tumor cells Molecular Carcinogenesis ·Vita Golubovskaya,Richard Finch,Frederick Kweh,Nicole Massoll,Martha Campbell‐Thompson,Margaret R. Wallace,William G. Cance	2007	83
13	Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues Cancer Research ·Shyra J. Miller,Fatima Rangwala,Jon Williams,Peter Ackerman,Sue Kong,Anil G. Jegga,Sérgio Kaiser,Bruce J. Aronow,Silke Frahm,Lan Kluwe,Victor Mautner,Meena Upadhyaya,David Muir,Margaret R. Wallace,Jussara Hagen,Dawn E. Quelle,Mark A. Watson,Arie Perry,David H. Gutmann,Nancy Ratner	2006	158
14	Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells Cancer Genetics and Cytogenetics ·Lauren Fishbein,Bonnie Eady,Nicholas A. Sanek,David Muir,Margaret R. Wallace	2005	21
15	Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia The American Journal of Cardiology ·Larisa M. Humma,Brian J. Puckett,Heather E. Richardson,Steven G. Terra,Tara E. Andrisin,Béatrice Lejeune,Margaret R. Wallace,Jannet F. Lewis,Dennis M. McNamara,Leslie Picoult-Newberg,Carl J. Pepine,Julie A. Johnson	2001	51
16	Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3d ed. Edited by J. M. Friedman, David H. Gutmann, Mia MacCollin, and Vincent M. Riccardi. Baltimore: Johns Hopkins Press, 1999. Pp. 380. $99.95 (hardcover only). The American Journal of Human Genetics ·Margaret R. Wallace	2000	7
17	Elastin Region Deletions in Williams Syndrome Genetic Testing ·Jun Zhang,Anil Kumar,Kyle J. Roux,Charles A. Williams,Margaret R. Wallace	1999	3
18	Two NF1 mutations: Frameshift in the GAP-related domain, and loss of two codons toward the 3′ end of the gene Human Mutation ·Corinne R. Abernathy,Steven D. Colman,Boris G. Kousseff,Margaret R. Wallace	1994	14
19	cDNA sequence and genomic structure of EVI2B, a gene lying within an intron of the neurofibromatosis type 1 gene Genomics ·Richard Cawthon,Lone B. Andersen,Arthur M. Buchberg,Gangfeng Xu,P. O’Connell,David Viskochil,Robert B. Weiss,Margaret R. Wallace,Douglas A. Marchuk,Melanie Culver,Jeffrey Stevens,Nancy A. Jenkins,Neal G. Copeland,Francis S. Collins,R. White	1991	92
20	Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis. Journal of Clinical Investigation ·Margaret R. Wallace,Francis E. Dwulet,Elliot Williams,P. M. Conneally,M D Benson	1988	60

About Margaret R. Wallace

Margaret R. Wallace is a scholar working on Neurology, Rheumatology and Anesthesiology and Pain Medicine, having authored 157 papers that have together received 9.0k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (73 papers), Sarcoma Diagnosis and Treatment (34 papers), Neuroblastoma Research and Treatments (24 papers), Soft tissue tumor case studies (20 papers), Musculoskeletal pain and rehabilitation (16 papers), Meningioma and schwannoma management (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers) and Shoulder Injury and Treatment (10 papers). The work is most often cited by research in Neurology (3.5k citations), Cellular and Molecular Neuroscience (1.4k citations) and Rheumatology (914 citations). Margaret R. Wallace has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Francis S. Collins, Lone B. Andersen, Ann M. Saulino, Douglas A. Marchuk, James F. Gusella, Roger B. Fillingim, P. Michael Conneally, Anna L. Mitchell, Nancy S. Wexler and Susan L. Naylor. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact